[Correlations between hemodynamics and therapy in the shock due to myocardial infarct].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001158:Arteries; D001794:Blood Pressure; D001810:Blood Volume; D002302:Cardiac Output; D003348:Cortisone / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006439:Hemodynamics; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology*; D010100:Oxygen / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use; D012769:Shock / Q000503:physiopathology* / Q000628:therapy; D013566:Sympathomimetics / Q000627:therapeutic use; D014655:Vascular Resistance; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014680:Veins
D000317:Adrenergic alpha-Antagonists; D004071:Digitalis Glycosides; D010952:Plasma Substitutes; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D010100:Oxygen; D003348:Cortisone
Correlazioni fra emodinamica e terapia nello shock da infarto miocardico.